Single-cell profiling reveals senescent bone marrow mesenchymal stem cell subpopulations driving pathological ossification in ankylosing spondylitis
Clicks: 5
ID: 326312
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
1.2
/100
5 views
4 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #48 of 206 articles by views in Lara D. Veeken
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 206 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
OBJECTIVES: Aberrant new bone formation is a hallmark of ankylosing spondylitis (AS), yet the cellular mechanisms remain unclear. Bone marrow-derived mesenchymal stem cells (BMSCs) are crucial for skeletal homeostasis and may be pathologically reprogrammed under chronic inflammation. We aimed to characterize the cellular heterogeneity and differentiation states of BMSCs in AS, identify BMSC subpopulations associated with structural damage, and explore their molecular features and potential therapeutic targets. METHODS: Single-cell RNA sequencing was performed on BMSCs from 12 AS patients stratified into severe structural damage (SSD, n = 9) and no structural damage (NSD, n = 3) groups based on mSASSS and SPARCC-SSS assessments. After quality control, 47,628 cells were analyzed by unsupervised clustering, trajectory inference, metabolic profiling, pathway enrichment,and in silico drug screening to characterize pathogenic subpopulations. RESULTS: The analysis revealed eight BMSC subpopulations forming a continuum from progenitors to lineage-committed cells. A distinct senescence-related cluster (SRC) was identified as the predominant population in patients with advanced syndesmophytes. The SRC displayed a dual phenotype of cellular senescence and hyperactive metabolism, characterized by elevated glycolysis and oxidative phosphorylation. This state supported the secretion of matrix-remodeling factors (MMP2) and inflammatory cytokines (IL-6). A specific gene signature (CDR1, PLPPR2, CMBL, SRXN1, and PPP1R3C) linked oxidative stress to this aberrant differentiation trajectory. Furthermore, computational prediction highlighted JAK inhibitors (baricitinib and filgotinib) as potential therapeutics to attenuate the SRC phenotype. CONCLUSION: This study identifies a senescence-associated, hypermetabolic BMSC subpopulation that is closely associated with structural progression in AS,providing a cellular basis for pathological bone formation and suggests that JAK inhibitors may serve as effective agents to reverse this pathogenic BMSC signature.
| Reference Key |
openalex_W7204121072
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Xiqing Luo, Jinwei Li, Jun Qi, Churong Lin, Jingxiao Wu, Ou Jin, Jieruo Gu |
| Journal | Lara D. Veeken |
| Year | 2026 |
| DOI |
10.1093/rheumatology/keag429
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.